171 related articles for article (PubMed ID: 23557481)
1. Structural and functional interactions of the prostate cancer suppressor protein NKX3.1 with topoisomerase I.
Song LN; Bowen C; Gelmann EP
Biochem J; 2013 Jul; 453(1):125-36. PubMed ID: 23557481
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response (DDR) via NKX3.1 expression in prostate cells.
Erbaykent-Tepedelen B; Karamil S; Gonen-Korkmaz C; Korkmaz KS
J Steroid Biochem Mol Biol; 2014 May; 141():26-36. PubMed ID: 24434284
[TBL] [Abstract][Full Text] [Related]
3. NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
Bowen C; Stuart A; Ju JH; Tuan J; Blonder J; Conrads TP; Veenstra TD; Gelmann EP
Cancer Res; 2007 Jan; 67(2):455-64. PubMed ID: 17234752
[TBL] [Abstract][Full Text] [Related]
4. Functional activation of ATM by the prostate cancer suppressor NKX3.1.
Bowen C; Ju JH; Lee JH; Paull TT; Gelmann EP
Cell Rep; 2013 Aug; 4(3):516-29. PubMed ID: 23890999
[TBL] [Abstract][Full Text] [Related]
5. NKX3.1 activates cellular response to DNA damage.
Bowen C; Gelmann EP
Cancer Res; 2010 Apr; 70(8):3089-97. PubMed ID: 20395202
[TBL] [Abstract][Full Text] [Related]
6. NKX3.1 contributes to S phase entry and regulates DNA damage response (DDR) in prostate cancer cell lines.
Erbaykent-Tepedelen B; Ozmen B; Varisli L; Gonen-Korkmaz C; Debelec-Butuner B; Muhammed Syed H; Yilmazer-Cakmak O; Korkmaz KS
Biochem Biophys Res Commun; 2011 Oct; 414(1):123-8. PubMed ID: 21945437
[TBL] [Abstract][Full Text] [Related]
7. Analysis of common gene expression patterns in four human tumor cell lines exposed to camptothecin using cDNA microarray: identification of topoisomerase-mediated DNA damage response pathways.
Guo X; Zhang J; Fu X; Wei Q; Lu Y; Li Y; Yin G; Mao Y; Xie Y; Rui Y; Ying K
Front Biosci; 2006 May; 11():1924-31. PubMed ID: 16368568
[TBL] [Abstract][Full Text] [Related]
8. Transcription-dependent activation of ataxia telangiectasia mutated prevents DNA-dependent protein kinase-mediated cell death in response to topoisomerase I poison.
Sakasai R; Teraoka H; Takagi M; Tibbetts RS
J Biol Chem; 2010 May; 285(20):15201-15208. PubMed ID: 20304914
[TBL] [Abstract][Full Text] [Related]
9. A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay.
Stewart L; Ireton GC; Champoux JJ
J Biol Chem; 1999 Nov; 274(46):32950-60. PubMed ID: 10551862
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
Rao VA; Fan AM; Meng L; Doe CF; North PS; Hickson ID; Pommier Y
Mol Cell Biol; 2005 Oct; 25(20):8925-37. PubMed ID: 16199871
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
Padmanabhan A; Gosc EB; Bieberich CJ
J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
[TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
[TBL] [Abstract][Full Text] [Related]
14. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. Interactions of the acidic domain and SRF interacting motifs with the NKX3.1 homeodomain.
Ju JH; Maeng JS; Lee DY; Piszczek G; Gelmann EP; Gruschus JM
Biochemistry; 2009 Nov; 48(44):10601-7. PubMed ID: 19780584
[TBL] [Abstract][Full Text] [Related]
17. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analysis of domains mediating interaction between the bagpipe homologue, Nkx3.1 and serum response factor.
Zhang Y; Fillmore RA; Zimmer WE
Exp Biol Med (Maywood); 2008 Mar; 233(3):297-309. PubMed ID: 18296735
[TBL] [Abstract][Full Text] [Related]
19. NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage.
Bowen C; Zheng T; Gelmann EP
Cancer Res; 2015 Jul; 75(13):2686-98. PubMed ID: 25977336
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
Tomicic MT; Kaina B
Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
